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What Happens to Bone MarroweDerived Cells
after Transplantation?
Regeneration of organs after injection of bone marrow (BM)e
derived cells into lethally irradiatedmice has been documented.
Taguchi et al (Am J Pathol 2013, 182:1255e1262) reported
similar organ regeneration on green ﬂuorescent protein-
positive (GFPþ) BM cell injection into lethally irradiated
wild-type mice. However, they observed that irradiation of the
cecum or spleen (only) blocked their regeneration with loss of
injected BM cells. In BM transplantationmice, intestinal GFPþ
stromal cells were regenerated fairly rapidly although GFPþ
cells were observed only rarely in the intestinal epithelium.
These ﬁndings suggest that the donor cells ﬁrst enter the BM
and then migrate to the peripheral organs. BM-derived stromal
cells thus play a pivotal role in epithelial renewal and are
crucial for maintaining organ structure and function.
CD44 Is Protective in Experimental
Autoimmune Encephalomyelitis
Adhesion molecule CD44, expressed by multiple cell types, is
implicated in various cellular and immunological processes.
Flynn et al (Am J Pathol 2013, 182:1322e1336) examined
the effect of global CD44 deﬁciency on myelin oligodendro-
cyte glycoprotein peptide (MOG)einduced experimental
autoimmune encephalomyelitis (EAE), a murine model of
multiple sclerosis. CD44-deﬁcient mice exhibited increased
disease severity, increased immune cells in the central nervous
system, increased anti-MOG antibody and proinﬂamma-
tory cytokine production, decreased numbers of peripheral
CD4þCD25þFoxP3þ regulatory T cells, and increased in vivo
permeability of the blood-brain barrier before and following
immunization. These data reveal multiple novel protective
roles of CD44 in EAE, with effects on cytokine production,
T-cell differentiation, T-celleendothelial cell interactions, and
blood-brain barrier integrity.
Autocrine Osteoclastogenesis in Giant Cell
Tumor of Bone
Giant cell tumor (GCT) of bone is a histologically benign
osteolytic tumor that affects young adults. Avnet et al (Am
J Pathol 2013, 182:1357e1366) demonstrated that theCopyright ª 2013 American Society for Investigative Pathology.
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http://dx.doi.org/10.1016/j.ajpath.2013.01.024nonproliferating CD14þ cells of GCTs secrete high amounts of
receptor activator of NF-kB ligand (RANKL), thereby acti-
vating a RANKL/RANK autocrine loop that determines sus-
tained giant cell formation. They also found impairment of the
normal negative feedback control of the RANK signaling
pathway by endogenous interferon-b. These data demonstrate
thatCD14þ cells ofGCTsare stimulated abnormally to limitless
differentiation into multinucleated giant cells, providing useful
suggestions for the development of novel therapies.
Mouse Models of Ovarian Cancer Progression
A dualistic pathway model of ovarian carcinoma pathogenesis
has been proposed: low grade type I ovarian carcinomas to
high-grade type II ovarian carcinomas. Wu et al (Am J Pathol
2013, 182:1391e1399) used a murine model of endometrioid
ovarian carcinoma, a prototypical type I tumor initiated by
conditional inactivation of the Apc and Pten tumor suppressor
genes, to investigate mutant Trp53 or Pik3ca alleles as key
drivers of type I/type II ovarian carcinoma progression. The
presence of somatic Trp53 or Pik3ca mutations resulted in
shortened survival andmorewidespreadmetastasis. Activation
of mutant Pik3ca with Pten inactivation resulted in papillary
hyperplasia. These ﬁndings indicate that the poor prognosis
associatedwithTP53 andPIK3CAmutations in human cancers
can be functionally replicated in this robust mouse model,
providing improved understanding of type I/type II ovarian
carcinoma progression.
IL-1b Induces Lymphangiogenesis, But Not
Angiogenesis, in Mouse Airways
IL-1b, a key inﬂammatory cytokine found inmany pathological
conditions, triggers multiple downstream inﬂammatory path-
ways.Baluk et al (AmJPathol 2013, 182:1434e1447) usedbi-
transgenic Clara cell secretory protein (CCSP)/IL-1b mice to
determine whether IL-1b can promote angiogenesis and lym-
phangiogenesis in mouse airways. Doxycycline treatment
induced rapid, abundant, and reversible IL-1b production, inﬂux
of neutrophils andmacrophages, and conspicuous and persistent
lymphangiogenesis, but surprisingly, no angiogenesis. Further,
they demonstrated that lymphangiogenesis is dependent on
vascular endothelial growth factor 3 ligands, opening avenues to
determine themechanisms regulating lymphatic vessel stability.
